U.S. markets closed
  • S&P Futures

    4,326.50
    -16.75 (-0.39%)
     
  • Dow Futures

    33,685.00
    -113.00 (-0.33%)
     
  • Nasdaq Futures

    14,957.50
    -66.50 (-0.44%)
     
  • Russell 2000 Futures

    2,170.80
    -10.10 (-0.46%)
     
  • Crude Oil

    70.51
    -0.05 (-0.07%)
     
  • Gold

    1,775.30
    -2.90 (-0.16%)
     
  • Silver

    22.48
    -0.13 (-0.58%)
     
  • EUR/USD

    1.1726
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    1.3240
    +0.0150 (+1.15%)
     
  • Vix

    24.36
    -1.35 (-5.25%)
     
  • GBP/USD

    1.3656
    -0.0008 (-0.06%)
     
  • USD/JPY

    109.1500
    -0.0700 (-0.06%)
     
  • BTC-USD

    41,135.84
    -1,422.20 (-3.34%)
     
  • CMC Crypto 200

    1,019.29
    -44.55 (-4.19%)
     
  • FTSE 100

    6,980.98
    +77.07 (+1.12%)
     
  • Nikkei 225

    29,839.71
    0.00 (0.00%)
     

PerkinElmer Agrees to Buy BioLegend for $5.25 Billion

·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

PerkinElmer agrees to buy BioLegend, a provider of antibodies and reagents, for about $5.25 billion in cash and stock.